NI
VNDA icon

Numeric Investors’s Vanda Pharmaceuticals VNDA Stock Holding History

Numeric Investors’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$9.55M Buy
628,000
+296,300
+89% +$4.4M 0.07% 274
2017
Q3 		$5.94M Buy
331,700
+102,800
+45% +$1.72M 0.05% 371
2017
Q2 		$3.73M Buy
228,900
+85,700
+60% +$1.24M 0.03% 390
2017
Q1 		$2M Sell
143,200
-353,400
-71% -$5.04M 0.02% 485
2016
Q4 		$7.92M Buy
496,600
+461,100
+1,299% +$7.41M 0.07% 257
2016
Q3 		$591K Sell
35,500
-7,400
-17% -$99.6K 0.01% 739
2016
Q2 		$480K Buy
42,900
+28,500
+198% +$276K ﹤0.01% 757
2016
Q1 		$120K Buy
14,400
+3,100
+27% +$25.4K ﹤0.01% 941
2015
Q4 		$105K Sell
11,300
-8,100
-42% -$80.8K ﹤0.01% 948
2015
Q3 		$219K Buy
19,400
+4,500
+30% +$55K ﹤0.01% 914
2015
Q2 		$189K Buy
14,900
+700
+5% +$7.55K ﹤0.01% 871
2015
Q1 		$132K Buy
14,200
+3,800
+37% +$42.9K ﹤0.01% 849
2014
Q4 		$149K Buy
+10,400
New +$123K ﹤0.01% 802
2014
Q1 		– Sell
-189,980
Closed -$2.36M – 910
2013
Q4 		$2.36M Buy
189,980
+169,080
+809% +$1.7M 0.04% 332
2013
Q3 		$229K Sell
20,900
-743,647
-97% -$7.95M ﹤0.01% 690
2013
Q2 		$6.18M Buy
+764,547
New +$5.15M 0.12% 166

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Numeric Investors's VNDA Position: Q4 2017 in Review

Numeric Investors increased its Vanda Pharmaceuticals (VNDA) stake by 89% in Q4 2017, buying an estimated $4.4M and bringing the position to 628,000 shares worth $9.55M. The position accounts for 0.07% of the portfolio, ranked #274.

Numeric Investors first reported a position in VNDA in Q2 2013 and has held it in 16 quarters since. 125 funds tracked by Wall St. Rank hold VNDA as of Q4 2017.

  • Numeric Investors held 628,000 shares of Vanda Pharmaceuticals worth $9.55M as of Q4 2017.
  • Numeric Investors bought 296,300 Vanda Pharmaceuticals shares in Q4 2017, an estimated $4.4M.
  • Vanda Pharmaceuticals made up 0.07% of Numeric Investors's portfolio in Q4 2017, its #274 holding.
  • Numeric Investors first reported a position in Vanda Pharmaceuticals in Q2 2013 and has held it in 16 quarters since.
  • 125 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.